Received Jul 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | EX434 | PO / MO |
Patient received a dose of vaccine on 07/01/2025 at 3:00 PM. The patient was checked out at 3:21 PM. At the time of the visit, neither the patient nor the parent expressed any concerns. Following the visit, the physician contacted the parent on 07/01/2025 to discuss any current symptoms and to disclose an error related to the vaccine administered. The parent reported no symptoms or concerns during the call. The physician provided ER precautions and gave the parent specific instructions regarding signs and symptoms of intussusception to monitor for at home.
None
None
N/A
NKDA
Physician discussed close monitoring for the next 2 days and 1 week and will be following uo with patient 07/02/2025